CD19 Car-T Cells

CD19 CAR-T cells are a type of advanced immunotherapy used to treat certain blood cancers, like some leukemias and lymphomas. They are made by collecting a patient's immune cells, modifying them in a lab so they can specifically recognize and attack cancer cells that display the CD19 protein on their surface. Once infused back into the patient, these engineered cells seek out and destroy the cancer cells, helping to eliminate the disease. This personalized treatment leverages the body's immune system to target cancer more precisely, offering hope for improved outcomes in otherwise difficult-to-treat blood cancers.